Ma Yun's right -handed horse Hua Teng, medical weapon capital big guy enters and retreat, there is surgery

A medical device company can be favored by Ma Yun and Ma Huateng at the same time, which may be unique in China.

On September 19, Yuyue Medical announced an announcement: Due to the needs of business development, the subsidiary Xun Jie Medical will introduce 291 million yuan in strategic investors in the form of capital increase and expansion. Xunjie Medical is the main body of the emergency sector of Yuyue Medical. AED, which is used for vibration defibrillation, is its main product.

The market soon discovered a new highlight: the strategic investor introduced by Yu Yue was Tencent. The market is interpreted as Tencent's optimistic about the emergency sector, so it has invested in this subsidiary of Yuyue.

Yuyue Medical is a medical device company created by Wu Guangming. It has always been the leader of domestic medical devices in domestic medical devices. In 2014, Yu Yue completed the "amazing", and acquired China Resources Wandong, a large equipment factory in the hospital, and intervened in the X -ray machine, nuclear magnetic, ventilator and other businesses. In 2018, Yuyue acquired Italian Parkson Medical and expanded overseas markets.

During this period, Ma Yun's Yunfeng Fund participated a lot. Wu Guangming himself is a limited partner of Yunfeng Fund. Among the several acquisitions, it is the shadow of capital leaders such as Ma Yun and the founder of Midea Health.

Today, I held hands again ...

Ma Huateng is optimistic about AED?

What is the purpose of investing in the news of Jie at this time? In this regard, Tencent stated that it would not comment.

Since 2022, the performance of Yuyue Medical First -aid has not good performance. The company's semi -annual report shows that the revenue of the emergency business was 63.8961 million yuan, a year -on -year decrease of 32.14%, which was almost all income from Xunjie Medical. However, Xunjie Medical does not make money itself, losing 28.37 million in the first half of the year.

The most important brand of Xunjie Medical is Primedic GMBH, which was founded in Germany in 1973. This is an old -brand AED brand and has a high popularity in the global medical emergency industry.

However, the fate of this company is not good. First, the US Space Laboratory Medical Instrument Co., Ltd., which was vertically integrated with professional electronic systems and components in 2014, was acquired by Spacelabs Medical. In 2017, it was sold to Yuyue Medical.

AED is a first -aid device that can rescue patients with non -professionals. After Yueyue Medical bought Pumeang, in December 2018, he invested 50 million yuan to set up a subsidiary Pumeng (Suzhou) Medical Technology Co., Ltd. in Suzhou to produce AED products in China.

It was just 4 years after the income pocket, Pu Meikang was still losing money. "In recent years, the international supply chain has been affected by the epidemic, and the shortage of core materials has basically been solved." Yu Yue Medical said to the Jianzhi Bureau, "Yu Yue has increased the domestic research and development investment of Pumeng. Products to solve the above supply chain and cost issues. "

AED currently depends on local government procurement and lover donations, and fewer people enter enterprises and families. According to the previous investigation and understanding of the Jianzhi Bureau (the Chinese medical device industry wonders: no one is willing to grab the 100 billion market), due to the high unit price of the product and the high operation and maintenance costs, the prospect of AED's full popularity is temporarily seen.

At this time, Tencent's shares of Xunjie Medical may not expect how much profit for the AED business. "Tencent agrees with Pu Meikang's development foundation in China's first aid. In the future, the two parties will continue to work together in the public emergency field." Yuyue Medical will be exposed.

AED products are mostly purchased by fiscal funds by local governments, or they are purchased by the Red Cross with charity funds as part of the public health system. The bidding enterprises are mainly Mai Rui, Jiu Xin, Coman, Lanfan, etc. Yu Yue is a rising star. Tencent has entered the public health market, and may have a deeper consideration.

Capital boss is getting low -key

For a long time, Yu Yue has been in the same connection with Ma Yun, and now it has been in Ma Huateng, which can be described as the scenery.

In 2014, the ice bucket challenged the prevailing, and the names of all walks of life hit the flowers and flowers, which aroused the concern of the society about "frozen disease". At that time, Wu Guangming, the richest man in Jiangsu, was invited to participate in the challenge by Kyushu General Manager Gong Yihua.

As a warrior, Wu Guangming can invite three friends. The first place he invited was Shen Nanpeng, the founding and execution partner of Sequoia Capital China Fund.

After Wu Guangming released the ice bucket challenge video, Yuyue Medical immediately issued an announcement: Yuyue Technology will transfer 7%of Yuyue Medical share capital to Shenzhen Qianhai Red Shirt Guangming Investment Management Center (limited partnership). At that time, Yuyue plans to acquire 51.51%of China Resources Wandong to enter the hospital's equipment market.

This is the first domestic case of private medical device companies to acquire central enterprise assets. Wu Guangming needs enough cash, and Shen Nanpeng set his handle.

Subsequently, Yunfeng Fund and Yu Rong participated in the direction of Wandong and entered Wu Guangming's Capital Bureau. In 2017, the three of Ma Yun, Yu Rong, and Wu Guangming also jointly shot to win the Italian company Parkson Medical for the main ultrasonic medical imaging solution and the special nuclear magnetic resonance imaging system.

In the year of the acquisition of Wandong Medical, Yuyue Medical has signed a three -year agreement with Ali Health. It will jointly cooperate in intelligent health hardware, medical imaging and chronic disease management. Get up and give people unlimited reveries.

At that time, there were media reports that the three -person combination of Ma Yun+Wu Guangming+Yu Rong may become a powerful force in the medical device circle. "

The good times are not long. Since 2018, the three have encountered some bumps one after another.

First of all, Wu Guangming's inside story was investigated.Wu Guangming used external accounts to make private transactions, and was eventually fined 37 million yuan, and he no longer served as the chairman of the company. Behind the scenes, his son Wu Qun took over Yuyue Medical.In April 2019, Wu Qun was only 31 years old when he served as chairman.Then Mei Nian Health has severely declined in 2019 due to goodwill impairment.Ali, Ant Group, and Yunfeng Fund shared the capital of the United States together in October 2019, and failed to restore the decline of US year's performance.

Then in 2020, the Ant Group IPO stopped.

Relatively speaking, in the past five years, Yuyue medical business has stabilized, product sales have grown annually, and in actively expanding new business areas, including POCT and other popular sectors, it is no wonder that Ma Huateng's attention has attracted Ma Huateng.

Capital operation is always just embellishment. After all, the pharmaceutical industry still has to return to the industry.

Writing | Nicotinamide

Edit ｜ Jiang Yun Jia Ting

Operation | Twenty -thirty

Illustration | Visual China

### Meinian Health#

- END -